FOAs: Revision Applications for Regenerative Medicine Innovation Projects (RMIP): R43/R44; R41/R42; U54; UM1; UC4; U24; R01; R24; UM2; P50; P41; U01

FOAs: Revision Applications for Regenerative Medicine Innovation Projects (RMIP) [R43/R44; R41/R42; U54; UM1; UC4; U24; R01; R24; UM2; P50; P41; U01].

These funding opportunity announcements (FOAs) invite revision applications, from investigators with active R43/R44; R41/R42; U54; UM1; UC4; U24; R01; R24; UM2; P50; P41; U01 research project awards that support clinical research studies on regenerative medicine (RM) using adult stem cells.

More details:

RFA-HL-17-023, R43/R44 Small Business Innovation Research (SBIR) Grant - Phase I, Phase II, Phase IIB, and Fast Track

RFA-HL-17-024, R41/R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, Phase IIB, and Fast Track

RFA-HL-17-025, U54 Specialized Center- Cooperative Agreements

RFA-HL-17-026, UM1 Research Project with Complex Structure Cooperative Agreement

RFA-HL-17-027, UC4 High Impact Research and Research Infrastructure - Cooperative Agreement Programs

RFA-HL-17-028, U24 Resource-Related Research Projects – Cooperative Agreements

RFA-HL-17-029, R01 Research Project Grant

RFA-HL-17-030, R24 Resource-Related Research Projects

RFA-HL-17-031, UM2 Program Project or Center with Complex Structure Cooperative Agreement

RFA-HL-17-032, P50 Specialized Center

RFA-HL-17-033, P41 Biotechnology Resource Grants

RFA-HL-17-034, U01 Research Project – Cooperative Agreements

 

Copyright ©2013 NHLBI Progenitor Cell Biology Consortium.

University of Maryland School of Medicine logo

National Heart Blood and Lung Institute logo